Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
140 studies found for:    HK1
Show Display Options
Rank Status Study
1 Completed Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine
Conditions: Influenza;   Virus Diseases
Intervention: Biological: H6N1 Teal HK 97/AA ca recombinant vaccine
2 Active, not recruiting Evaluating the Safety and Immune Response to an H5N1 Influenza Vaccine in People Who Have Previously Received an H5N1 or H7N3 Influenza Vaccine and in People Who Have Never Received a Live Attenuated Influenza Vaccine
Condition: H5N1 Influenza
Intervention: Biological: H5N1 Vaccine
3 Enrolling by invitation Lime Powder Regimen in Healthy Volunteers
Conditions: Kidney Stone;   Oxidative Stress
Intervention: Dietary Supplement: Lime powder regime
4 Unknown  Study to Evaluate Induction Chemotherapy Using Docetaxel, Cisplatin and Fluorouracil in Concurrence With Intensity-modulated Radiotherapy for Local Recurrent Nasopharyngeal Carcinoma (NPC)
Condition: Nasopharyngeal Carcinoma
Intervention: Drug: Docetaxel, Cisplatin, 5-FU and Cetuximab
5 Terminated
Has Results
Evaluation of Safety and Effectiveness of Fostamatinib Compared to Placebo in Patients in Asia With Rheumatoid Arthritis
Condition: Rheumatoid Arthritis
Interventions: Drug: Fostamatinib;   Drug: Placebo
6 Completed Health Effects Following Use of Lead Free Ammunition Used With HK416
Conditions: Lung Function Tests;   Markers of Inflammation
7 Active, not recruiting A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: PF-00547659 SC Injection
8 Completed H-IVIG Treatment for Severe H1N1 2009
Condition: Novel 2009 Influenza A (H1N1) Infection
Interventions: Drug: Hyperimmune intravenous immunoglobulin;   Drug: Intravenous immunoglobulin
9 Active, not recruiting Efficacy and Safety of Sofosbuvir Plus Ribavirin in Subjects With Chronic HCV Infection
Condition: Chronic HCV Infection
Interventions: Drug: Sofosbuvir;   Drug: RBV
10 Completed Hemoglobin Kinetics in Response to Mircera® in Patients With Acute Myocardial Infarction
Condition: Acute Myocardial Infarction
Intervention: Drug: methoxy-polyethyleneglycol epoetin beta
11 Recruiting The Joint Asia Diabetes Evaluation (JADE) Program in Hong Kong Community
Condition: Type 2 Diabetes Mellitus
Intervention: Other: Protocol-driven care under JADE Program
12 Recruiting This is a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder
Conditions: Overactive Bladder;   Urgency Incontinence;   Urinary Bladder Overactive;   Urinary Bladder Diseases\Urologic Diseases
Interventions: Drug: Solifenacin Succinate;   Drug: Mirabegron;   Drug: Placebo
13 Unknown  Comparison of Two Doses of Intranasal Dexmedetomidine as Premedication in Children
Condition: Patient Between 1-8 Years Old Undergoing Elective Surgery at Queen Mary Hospital
Intervention: Drug: Dexmedetomidine
14 Recruiting Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC
Condition: Hepatocellular Carcinoma
Intervention: Biological: PACOX
15 Recruiting A Study Evaluating The Efficacy And Safety Of CP-690,550 In Patients With Moderate To Severe Ulcerative Colitis
Condition: Ulcerative Colitis
Interventions: Drug: tofacitinib;   Drug: Placebo
16 Unknown  PEARL Program: Empowerment Program for Patients With Type 2 Diabetes (HK4)
Condition: Diabetes
Interventions: Behavioral: Patient Peer Support and Empowerment;   Behavioral: Usual Care
17 Completed Fluoxetine vs. Brief Psychotherapy for Major Depression
Condition: Major Depressive Disorder
Interventions: Drug: Fluoxetine;   Behavioral: Short-term psychodynamic psychotherapy
18 Active, not recruiting A Study To Assess The Efficacy And Safety Of PF-04236921 In Subjects With Crohn's Disease Who Failed Anti-TNF Therapy
Condition: Crohn's Disease
Intervention: Drug: PF-04236921 SC injection
19 Completed
Has Results
An Efficacy and Safety Study of Rivaroxaban With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Patients With Non-Valvular Atrial Fibrillation
Conditions: Atrial Fibrillation;   Stroke;   Embolism
Interventions: Drug: Rivaroxaban;   Drug: Warfarin;   Drug: Matching placebo for Rivaroxaban arm (Warfarin placebo);   Drug: Matching placebo for Warfarin arm (Rivaroxaban placebo)
20 Recruiting Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis
Condition: Ulcerative Colitis
Intervention: Drug: CP-690,550

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years